Download Free Economic And Social Consequences Of Biotechnology Book in PDF and EPUB Free Download. You can read online Economic And Social Consequences Of Biotechnology and write the review.

There are currently many controversial socioeconomic issues concerned with the development and implementation of agricultural biotechnology. This book presents selected revised and edited papers from the fourth and fifth meetings of the International Consortium on Agricultural Biotechnology Research, held in Italy in 2000 and 2001.
`Biotechnology' - the integrated use of biochemistry, microbiology, and chemical engineering for the technological application of the capabilities of microbes and cultured tissue cells - is quickly becoming pervasive and challenging, rapidly developing both new techniques and industries. The Economic and Social Dynamics of Biotechnology - a joint project between Statistics Canada, the Program of Research on Innovation, Management and Economy (PRIME) at the University of Ottawa, and CIRANO at the University of Quebec in Montreal - brings together economic, social, and statistical views on the dynamics of this set of emerging technologies. It examines the costs as well as the benefits - the challenges as well as the choices - of the rapidly expanding science-based world of biodiversity, biopharmaceuticals, and bioinformatics, and it provides suggestions for future work and research. This project fits into an ongoing research program at Statistics Canada to develop meaningful indicators for science, technology, and innovation in a technology-intensive economy. This book tells the story of the inner workings of innovation systems, technological systems, and competence blocs in the production, use, and diffusion of knowledge.
The principal message of this book is that thermodynamics and statistical mechanics will benefit from replacing the unfortunate, misleading and mysterious term "entropy" with a more familiar, meaningful and appropriate term such as information, missing information or uncertainty. This replacement would facilitate the interpretation of the "driving force" of many processes in terms of informational changes and dispel the mystery that has always enshrouded entropy. It has been 140 years since Clausius coined the term "entropy"; almost 50 years since Shannon developed the mathematical theory of "information"--Subsequently renamed "entropy." In this book, the author advocates replacing "entropy" by "information," a term that has become widely used in many branches of science. The author also takes a new and bold approach to thermodynamics and statistical mechanics. Information is used not only as a tool for predicting distributions but as the fundamental cornerstone concept of thermodynamics, held until now by the term "entropy." The topics covered include the fundamentals of probability and information theory; the general concept of information as well as the particular concept of information as applied in thermodynamics; the re-derivation of the Sackur-Tetrode equation for the entropy of an ideal gas from purely informational arguments; the fundamental formalism of statistical mechanics; and many examples of simple processes the "driving force" for which is analyzed in terms of information.
Adding yet another dimension to the debate on biotechnology that already encompasses technology and ethics, four Canadian economists and a Welsh scholar of management look at how the field may bring about significant economic upheavals, focusing on the agrifood industrial complex and specifically avoiding any consideration of human medical and pharmaceutical aspects. The topics include intellectual property, the environment, consumer issues, who gets biotechnology rents, and international issues. c. Book News Inc.
This book was first published in 1992. This book deals with an area of great importance: the issues involved in developing biotechnologically based industries in the developing countries. The science and most of the techniques are well established and it is often possible to obtain the desired finance. This book, however, examines the sort of choices that a developing country has to make as to whether to go ahead with any of the projects outlined in the book and their likely socio-economic consequences. Each chapter is written by experts in their field and discusses the current biotechnologically based industries and their state of development, their suitability for various economies and the problems associated with developing them. Chapters discuss environmental questions and further socio-economic factors that need to be considered in order to bring about successful wealth creation in these countries. This book will be invaluable reading for all those interested in biotechnology and its application to the developing world.
Breakthroughs in biotechnology are redefining the very concept of life, transforming society and presenting unprecedented opportunities and challenges: Will human genome sequencing help to treat genetic diseases and indefinitely prolong life? Will stem cell therapy and tissue engineering allow routine regeneration and replacement of diseased organs? Can new diagnostic tests revolutionize medicine and healthcare? Will genetic engineering allow parents to design perfect babies? Can nature’s workshop inspire superior biomaterials that transform industries? Will genetically modified super crops feed a hungry world? With biotechnology set to be the driving force of the twenty-first century, mastery of the life sciences will be the key to wealth generation and economic ascendancy. Can the Arab World regain its past supremacy in these fields? Can it benefit from the biotech revolution while avoiding its perils? Such implications were debated by experts at the ECSSR Eighth Annual Conference titled Biotechnology and the Future of Society: Challenges and Opportunities, held from January 11-13, 2003 in Abu Dhabi, United Arab Emirates. This volume of conference presentations explores the broad impact of the biotech revolution, highlighting trends in healthcare and molecular medicine, the genetic revolution in agriculture, the future of materials production, new drug discovery technologies and national security issues, including the threat of bio-terrorism. It also examines the complex ethical, legal and social issues raised by the biotech revolution that need to be resolved by governments and decision makers.
Within the context of the Convention on Biological Diversity (CBD), the Cartagena Protocol on Biosafety (CPB) was established as an implementing agreement. The CPB is an international agreement establishing the rights of recipient countries to be notified of and to approve or reject the domestic import and/or production of living modified organisms (LMOs). Decisions regarding import/production are to be on the basis of a biosafety assessment. Article 26.1 of the CPB allows for the (optional) inclusion of socio-economic considerations (SECs) into that biosafety assessment process. This book compiles expert assessments of the issues relevant to SEC assessment of LMOs and fundamental for decisions regarding whether to undertake such assessments at all. It includes an overview of the inclusion of SEC assessment in the regulation of LMOs that looks at the rationale for the inclusion of SECs, in the context of the existing science-based risk assessment systems. This book reviews the various factors that can and have been suggested for inclusion in SEC assessment, and provides a meaningful dialogue about the contrasts, benefits and tradeoffs that are, and will, be created by the potential move to the inclusion of SECs in the regulation of LMOs, making it of interest to both academics and policy-makers.
The American chestnut, whitebark pine, and several species of ash in the eastern United States are just a few of the North American tree species that have been functionally lost or are in jeopardy of being lost due to outbreaks of pathogens and insect pests. New pressures in this century are putting even more trees at risk. Expanded human mobility and global trade are providing pathways for the introduction of nonnative pests for which native tree species may lack resistance. At the same time, climate change is extending the geographic range of both native and nonnative pest species. Biotechnology has the potential to help mitigate threats to North American forests from insects and pathogens through the introduction of pest-resistant traits to forest trees. However, challenges remain: the genetic mechanisms that underlie trees' resistance to pests are poorly understood; the complexity of tree genomes makes incorporating genetic changes a slow and difficult task; and there is a lack of information on the effects of releasing new genotypes into the environment. Forest Health and Biotechnology examines the potential use of biotechnology for mitigating threats to forest tree health and identifies the ecological, economic, and social implications of deploying biotechnology in forests. This report also develops a research agenda to address knowledge gaps about the application of the technology.
Raising hopes for disease treatment and prevention, but also the specter of discrimination and "designer genes," genetic testing is potentially one of the most socially explosive developments of our time. This book presents a current assessment of this rapidly evolving field, offering principles for actions and research and recommendations on key issues in genetic testing and screening. Advantages of early genetic knowledge are balanced with issues associated with such knowledge: availability of treatment, privacy and discrimination, personal decision-making, public health objectives, cost, and more. Among the important issues covered: Quality control in genetic testing. Appropriate roles for public agencies, private health practitioners, and laboratories. Value-neutral education and counseling for persons considering testing. Use of test results in insurance, employment, and other settings.